GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » JTEC Corporation (TSE:3446) » Definitions » Net Current Asset Value

JTEC (TSE:3446) Net Current Asset Value : 円72.53 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is JTEC Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

JTEC's net current asset value per share for the quarter that ended in Mar. 2024 was 円72.53.

The historical rank and industry rank for JTEC's Net Current Asset Value or its related term are showing as below:

TSE:3446' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 14.2   Med: 27.48   Max: 86.47
Current: 21.91

During the past 7 years, the highest Price-to-Net-Current-Asset-Value Ratio of JTEC was 86.47. The lowest was 14.20. And the median was 27.48.

TSE:3446's Price-to-Net-Current-Asset-Value is ranked worse than
86.47% of 584 companies
in the Medical Devices & Instruments industry
Industry Median: 4.895 vs TSE:3446: 21.91

JTEC Net Current Asset Value Historical Data

The historical data trend for JTEC's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JTEC Net Current Asset Value Chart

JTEC Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Net Current Asset Value
Get a 7-Day Free Trial 202.80 178.77 59.43 51.52 117.71

JTEC Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.67 117.71 101.77 81.53 72.53

Competitive Comparison of JTEC's Net Current Asset Value

For the Medical Instruments & Supplies subindustry, JTEC's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JTEC's Price-to-Net-Current-Asset-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, JTEC's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where JTEC's Price-to-Net-Current-Asset-Value falls into.



JTEC Net Current Asset Value Calculation

JTEC's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Jun. 2023 is calculated as

Net Current Asset Value Per Share(A: Jun. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1677.316-986.11-0-0)/5.87206
=117.71

JTEC's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2024 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1288.817-862.432-0-0)/5.879
=72.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JTEC  (TSE:3446) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


JTEC Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of JTEC's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


JTEC (TSE:3446) Business Description

Traded in Other Exchanges
N/A
Address
2-5-38 Saito-Yamabuki, Ibaraki-shi, Osaka, JPN, 567-0086
JTEC Corporation is engaged in developing, designing, manufacturing and sales of Automated Cell Culture System; X-ray Mirrors for Synchrotron Facilities; and Automated System in various fields. Its products in optical business include Kirkpatrick-Baez (KB) mirror, Advanced KB mirror (1D Wolter mirror), Montel mirror, Ellipsoidal mirror, 2D Walter mirror, Deformable mirror, Multi-channel mirror, X-ray focusing alignment system (JM1000 / 2000 series), Additional mirror shaping improvement, and Mirror coating. Its products in life science include CELLFLOAT products and Automated Cell Culture Systems.

JTEC (TSE:3446) Headlines

No Headlines